Influenza vaccines are recommended annually, but there’s now an increasing number of different vaccine types. Here’s what to know about this year’s shots.
The groundbreaking identification of a specific T-cell receptor in healthy people without lupus has the potential to treat not only that disease, but approximately 100 autoimmune diseases known to have a similar pathology.
The beginning of the new school year begins today in Victoria, and for some families the date fills them with trepidation.
School-leavers want flexibility and gig work offers it. But how will that affect the economy?
The TGA has just approved a vaccine against RSV for Australians over 60. Here’s where protection is up to for the youngest children, who are also at risk from the virus.
So far, Israel’s war in Gaza hasn’t greatly disrupted global supply chains. But the situation could quickly shift along many fault lines.
Gender-based violence is a national crisis, one the university sector is not immune from, and we need to step up now.
Antibiotics have been around for less than a century. But as resistant bacteria become increasingly difficult to treat, we risk a greater number of deaths from infections.
The drug donanemab is being hailed as a turning point in the fight against Alzheimer’s, following a global trial that confirms it can slow cognitive decline.
Can genetically-modified cell therapies correct the immune system’s mistaken attack of healthy cells and tissues?
XBB. 1.5 and other subvariants do signal a change in how the virus is mutating. Here’s what this means for Australia and globally.
The Omicron strain is driving a rapid increase in China, and is quicker to transmit than other variants.
It’s a long-term treatment – people having allergen immunotherapy typically notice improved symptoms after six to 12 months.
German doctors have reported success in treating patients with severe lupus, using cell treatments like those used for some forms of blood cancer.
The virus is related to Hendra and Nipah viruses. But we don’t know whether it spreads from human to human.
Professor Jamie Rossjohn is internationally recognised for using structural biology to investigate how T cells can respond to viral infections or cause autoimmunity. Now, he's been named a fellow of the oldest science academy in the world.
Could a combination of phage therapy and antibiotics be the key to unlocking the antimicrobial-resistant superbug crisis?
Antibiotic-resistant bacteria causes 700,000 deaths annually, but there are strategies we can use to slow the rapid rise of these superbugs.
The pandemic stretched our healthcare system to breaking point, but it also proved how new and positive models of screening and care can quickly be created in adversity.
Why aren’t we creating more art about this metamorphic life stage experienced by half the population?
The bill exposes the culture war within Australia’s biggest religious groups, and runs into constitutional problems.
2022 will be the year we finally have all the means, measures, and tools to control the pandemic to a non-lethal state.
The new variant of interest, detected in 42 countries, possesses a “constellation of mutations that indicate potential properties of immune escape”.
Dummy text